Derrick Hall satisfied with Dbacks buying and se

first_img Derrick Hall satisfied with D-backs’ buying and selling And let’s make no mistake about this. If Fitz leaves and plays elsewhere it does nothing to tarnish his reputation in Arizona. He is and he always will be one of the greatest Cardinals players and one of the greatest athletes to ever play in Arizona. He is a future Ring of Honor member and a future Cardinals Hall of Famer. I mean, let’s be honest. It sucked that Steve Nash went to play for the Los Angeles Lakers, but he will go in the Suns Ring of Honor and always be remembered for his two MVP awards and that 7-seconds-or-less offense. Aeneas Williams and Larry Centers, both legendary Cardinals players, both finished their careers with other organizations. Emmitt Smith, Jerry Rice, Eric Dickerson, Peyton Manning, Johnny Unitas and Tony Dorsett are just a few of the greatest players in NFL history that finished their careers playing for someone other than where they became legendary. Fitz is still good. But he is a glorified tight end in this offense. He is a slot receiver. They don’t run fade routes to him. They don’t go downfield to him. That job is now Michael Floyd and John Brown’s. He is a third option at best and his numbers show that. He is not a 1,000-yard receiver anymore, at least not in this offense. The 5: Takeaways from the Coyotes’ introduction of Alex Meruelo Grace expects Greinke trade to have emotional impact Former Cardinals kicker Phil Dawson retires Again, he is still good. He can help the Cardinals win games. And for 11 years he has been paid like one of the best players in the game. Now, it’s time for him to play for the pay he is worth. And if he doesn’t want to do that then you simply say “thank you” for all you have done and we will see you in a few years when we hang a banner with your name on it from the University of Phoenix Stadium rafters.center_img 0 Comments   Share   No one, not even Larry Fitzgerald himself knows for sure if Saturday’s game against the Carolina Panthers will be his final game in an Arizona Cardinals uniform. Only time will tell.Arizona general manager Steve Keim has said all the right things about wanting Fitzgerald to return for a 12th season in Arizona. Keim has talked about wanting Fitz to retire as a Cardinal. He has mentioned having his 2015 salary and cap number already budgeted. But Keim has never guaranteed he would come back only saying it is his intent to have him back. Top Stories The face of the franchise is scheduled to count an astonishing $23.6 million dollars against the salary cap next season. That’s a lot of money and Arizona could probably do a few things if they either cut Fitz or get him to take a massive pay cut. By cutting him before June 1, Arizona could save $9.2 million dollars on the cap and get his contract, which runs through 2018, off their books. A trade is possible but probably a longshot, although a team trading for Fitzgerald would likely rip up the current contract and give him a new deal.Look I know its not the popular decision here but I have no problem with Arizona cutting Larry if he doesn’t want to play for what his true value is and that’s probably around $8 million dollars per year on a short-term deal. Anquan Boldin, the former Cardinals wideout, signed a 2-year $12 million dollar deal with the 49ers and although he’s two years older, he has had back-to-back 1,000-yard seasons and is more productive than his former teammate. I know, I know. How could anyone want to see Fitz playing in another uniform. He has meant so much to this organization and this community. I get it. I do. But, it’s a business and it makes NO business sense to keep the franchise’s all-time receiving leader at the money he is scheduled to make. last_img read more

GAO Report Says More Medicare Advantage Network Oversight Needed

first_img The U.S. Centers for Medicare and Medicaid Services must do more to ensure that health insurance plans offered through Medicare Advantage, a private alternative to traditional Medicare, have adequate networks, according to a government report. (Pierson, 9/30) Reuters: GAO Report Calls For Tougher Oversight Of Medicare Advantage Plans Kaiser Health News: Poll Finds Overwhelming Support For Medicare Paying For End-Of-Life Talks CNBC: Medicare Drug Plan Prices Set To Rise In 2016, Some By A Lot The New York Times: Nursing Homes Bill For More Therapy Than Patients Need, U.S. Says Seniors, get ready to dig deeper into your wallets, or to start shopping more. More than 15 million people enrolled in the top 10 Medicare “Part D” prescription drug plans will face average premium hikes of 8 percent next year, according to a new analysis. Those top 10 plans account for more than 80 percent of enrollment in such drug plans, the Avalere Health consultancy found. Five of the top prescription drug plans will see double-digit premium hikes next year. (Mangan, 9/29) center_img GAO Report Says More Medicare Advantage Network Oversight Needed In other Medicare news, Part D drug prices are set to rise in 2016, some by a lot. Elsewhere, a new poll finds wide support for Medicare paying for end-of-life conversations, and another report finds nursing homes get much more in Medicare payments than it costs them to provide care. This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. The public overwhelmingly supports Medicare’s plan to pay for end-of-life discussions between doctors and patients, despite GOP objections that such chats would lead to rationed care for the elderly and ill, a poll released Wednesday finds. (Rau, 9/30) Nursing homes receive far more in Medicare payments than it costs them to provide care, exploiting the billing system in some cases by giving patients more therapy services than they need, federal investigators said in a new report. The report, to be issued on Wednesday by the inspector general of the Department of Health and Human Services, said that nursing homes regularly filed claims for the highest, most expensive level of therapy, regardless of what patients required. (Pear, 9/30) last_img read more